drugset / Trial / NCT02499315
Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to find out if AMG 357 is safe and tolerated by women with Rhematoid Arthritis.
Timeline
- Start
- 2015-04
- Primary completion
- 2016-02
- Completion
- 2016-02
Outcome
Outcome not reported
Stopped: “Study has stopped due to a decision by Amgen to terminate the program”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMG 357 | Small molecule | 5 mg | Oral |
| Subject | AMG 357 | Small molecule | 25 mg | Oral |
| Subject | AMG 357 | Small molecule | 50 mg | Oral |